A disciplined, highly targeted approach to discovering new cancer medicines
Rigorous, definitive clinical trials based on deep oncology expertise
Committed to bringing differentiated new cancer medicines to patients
ARIAD's first internally discovered and developed medicine
ARIAD Announces Data Presentations at the European Hematology Association (EHA) Congress
ARIAD to Present at the Jefferies 2015 Global Healthcare Conference
A shared commitment to patients and each other. This is ARIAD.